Jf. Flejou et al., OVEREXPRESSION OF P53 PROTEIN IN BARRETTS -ESOPHAGUS - A FREQUENT ANDEARLY EVENT DURING CARCINOGENESIS, Gastroenterologie clinique et biologique, 19(5), 1995, pp. 475-481
Objectives and methods. In Barrett's oesophagus, the risk of malignanc
y is evaluated histologically with the pre sence of dysplasia. The abn
ormal expression of p53 protein could represent a useful new marker. T
he aim of this study was evaluate the abnormal expression of p53 prote
in in a series of 52 oesophagectomy specimens with Barrett's oesophagu
s, either non-dysplastic (n = 3), dysplastic (n = 8), or malignant (n
= 41). The immunohistochemical study was made on deparaffinized sectio
ns with the monoclonal anti-p53 antibody DO7. Results. - The 3 non-dys
plastic cases were p53 negative; 1 case of low-grade dysplasia in 5 wa
s positive, as were the 3 cases of high grade dysplasia and 33 of 41 c
ancers (80 %), including 13 superficial cancers in 14 (93 %) and 20 in
vasive cancers in 27 (74 %). A common feature was the presence of rare
p53 positive crypts in low grade dysplastic areas and non-dysplastic
specialized mucosa that surrounded high grade dysplasia and cancers. C
onclusions. - Our results confirm the high frequency of the abnormal e
xpression of p53 protein in cancer developped in Barrett's oesophagus.
This expression is a consequence of alterations of the TP53 gene, and
has an important role in the carcinogenesis of Barrett's mucosa; it i
s likely to represent an early event. Prospective studies are needed t
o evaluate its interest in the surveillance of patients with Barrett's
oesophagus.